355 related articles for article (PubMed ID: 33922083)
61. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).
Goncharova EA; Goncharov DA; Eszterhas A; Hunter DS; Glassberg MK; Yeung RS; Walker CL; Noonan D; Kwiatkowski DJ; Chou MM; Panettieri RA; Krymskaya VP
J Biol Chem; 2002 Aug; 277(34):30958-67. PubMed ID: 12045200
[TBL] [Abstract][Full Text] [Related]
62. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.
McCarthy C; Gupta N; Johnson SR; Yu JJ; McCormack FX
Lancet Respir Med; 2021 Nov; 9(11):1313-1327. PubMed ID: 34461049
[TBL] [Abstract][Full Text] [Related]
63. Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis.
Ando K; Kurihara M; Kataoka H; Ueyama M; Togo S; Sato T; Doi T; Iwakami S; Takahashi K; Seyama K; Mikami M
Respir Investig; 2013 Sep; 51(3):175-83. PubMed ID: 23978644
[TBL] [Abstract][Full Text] [Related]
64. Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment.
Cao J; Huang W
PLoS One; 2016; 11(2):e0149388. PubMed ID: 26872016
[TBL] [Abstract][Full Text] [Related]
65. Improving bulk RNA-seq classification by transferring gene signature from single cells in acute myeloid leukemia.
Wang R; Zheng X; Wang J; Wan S; Song F; Wong MH; Leung KS; Cheng L
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35136933
[TBL] [Abstract][Full Text] [Related]
66. Single-cell and single-nucleus RNA-sequencing from paired normal-adenocarcinoma lung samples provide both common and discordant biological insights.
Renaut S; Saavedra Armero V; Boudreau DK; Gaudreault N; Desmeules P; Thériault S; Mathieu P; Joubert P; Bossé Y
PLoS Genet; 2024 May; 20(5):e1011301. PubMed ID: 38814983
[TBL] [Abstract][Full Text] [Related]
67. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
MacKeigan JP; Krueger DA
Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
[TBL] [Abstract][Full Text] [Related]
68. Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus.
Takia L; Jat KR; Mandal A; Kabra SK
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413450
[TBL] [Abstract][Full Text] [Related]
69. Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis.
Gopalakrishnan V; Yao J; Steagall WK; Avila NA; Taveira-DaSilva AM; Stylianou M; Chen MY; Moss J
Chest; 2019 May; 155(5):962-971. PubMed ID: 30660784
[TBL] [Abstract][Full Text] [Related]
70. Human Pluripotent Stem Cell-Derived
Julian LM; Delaney SP; Wang Y; Goldberg AA; Doré C; Yockell-Lelièvre J; Tam RY; Giannikou K; McMurray F; Shoichet MS; Harper ME; Henske EP; Kwiatkowski DJ; Darling TN; Moss J; Kristof AS; Stanford WL
Cancer Res; 2017 Oct; 77(20):5491-5502. PubMed ID: 28830860
[TBL] [Abstract][Full Text] [Related]
71. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
Kim ST; Kim SY; Klempner SJ; Yoon J; Kim N; Ahn S; Bang H; Kim KM; Park W; Park SH; Park JO; Park YS; Lim HY; Lee SH; Park K; Kang WK; Lee J
Ann Oncol; 2017 Mar; 28(3):547-554. PubMed ID: 28028034
[TBL] [Abstract][Full Text] [Related]
72. The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.
Wang Q; Luo M; Xiang B; Chen S; Ji Y
Respir Res; 2020 Feb; 21(1):55. PubMed ID: 32059669
[TBL] [Abstract][Full Text] [Related]
73. Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors.
Martignoni G; Pea M; Reghellin D; Gobbo S; Zamboni G; Chilosi M; Bonetti F
Arch Pathol Lab Med; 2010 Jan; 134(1):33-40. PubMed ID: 20073603
[TBL] [Abstract][Full Text] [Related]
74. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.
Fujita A; Ando K; Kobayashi E; Mitani K; Okudera K; Nakashima M; Miyatake S; Tsurusaki Y; Saitsu H; Seyama K; Miyake N; Matsumoto N
Hum Genet; 2016 Jan; 135(1):61-8. PubMed ID: 26563443
[TBL] [Abstract][Full Text] [Related]
75. Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis.
Mohammadieh AM; Bowler SD; Silverstone EJ; Glanville AR; Yates DH
Med J Aust; 2013 Jul; 199(2):121-3. PubMed ID: 23879512
[TBL] [Abstract][Full Text] [Related]
76. Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation.
Espinosa M; Roldán-Romero JM; Duran I; de Álava E; Apellaniz-Ruiz M; Cascón A; Garrigos C; Robledo M; Rodriguez-Antona C
BMC Cancer; 2018 May; 18(1):561. PubMed ID: 29764404
[TBL] [Abstract][Full Text] [Related]
77.
Ho DWH; Chan LK; Chiu YT; Xu IMJ; Poon RTP; Cheung TT; Tang CN; Tang VWL; Lo ILO; Lam PWY; Yau DTW; Li MX; Wong CM; Ng IOL
Gut; 2017 Aug; 66(8):1496-1506. PubMed ID: 27974549
[TBL] [Abstract][Full Text] [Related]
78. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.
Freitas CS; Baldi BG; Araújo MS; Heiden GI; Kairalla RA; Carvalho CR
J Bras Pneumol; 2015; 41(3):275-80. PubMed ID: 26176526
[TBL] [Abstract][Full Text] [Related]
79. [A rare cause of edema: sporadic lymphangioleiomyomatosis].
Frank H; Weiss W
Dtsch Med Wochenschr; 2013 Sep; 138(38):1892-5. PubMed ID: 24022453
[TBL] [Abstract][Full Text] [Related]
80. Lymphangioleiomyomatosis: New Treatment Perspectives.
Radzikowska E
Lung; 2015 Aug; 193(4):467-75. PubMed ID: 25980593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
